Related Experiment Video
Updated: Jun 3, 2026
06:57
The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
Published on: May 8, 2017
Pneumothorax in cystic fibrosis
1Departments of Medicine and Pediatrics, Medical University of South Carolina, Charleston, SC 29425, USA. flumepa@musc.edu
Current Opinion in Pulmonary Medicine
|April 5, 2011
Summary
Cystic fibrosis (CF) patients may develop pneumothorax, a serious lung complication. New recommendations offer guidance for managing this condition in CF patients.
Area of Science:
- Pulmonology
- Genetics
- Medical Complications
Background:
- Cystic Fibrosis (CF) is a genetic disorder primarily impacting lung function, leading to 85% of mortality.
- Lung disease in CF involves infection, inflammation, bronchiectasis, and airway obstruction, increasing risks of complications like pneumothorax.
- Pneumothorax is a serious respiratory complication that can arise as CF lung disease progresses.
Purpose of the Study:
- To review the current understanding of pneumothorax pathogenesis in Cystic Fibrosis.
- To outline the established treatment strategies for pneumothorax in CF patients.
Main Methods:
- Expert panel consensus process.
- Review of existing literature and clinical data.
- Development of treatment recommendations.
Main Results:
- The CF Foundation Pulmonary Therapies Committee has issued new recommendations for managing hemoptysis and pneumothorax in CF.
- These recommendations were established through an expert consensus process due to a lack of sufficient data for a systematic review.
- Guidance is now available for the specific care of CF patients experiencing pneumothorax.
Conclusions:
- Specific care recommendations for Cystic Fibrosis patients with pneumothorax are now available.
- These guidelines aim to standardize and improve the management of pneumothorax in the CF population.
Related Concept Videos
01:26Pneumothorax-I
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
01:27Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
01:08Pneumothorax II: Pathophysiology
Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:13Pleura of the Lungs
The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...